These picks are based on James Altucher's just-released book, The Forever Portfolio. Be sure to read the
ResMed (RMD) reported earnings and revenue that fell short of analysts' expectations for the 2017 fiscal first quarter.
Cramer is concerned about Dave & Buster's but says Chipotle's problems are behind it.
When it comes to stock prices, competition has a lot of influence, Cramer says.
Jefferies reduced its rating on ResMed (RMD) stock to 'underperform' from 'hold' on Tuesday.